Cargando…
The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer
Irisin (Ir) is an adipomyokine formed from fibronectin type III domain-containing protein 5 (FNDC5), which can be found in various cancer tissues. Additionally, FNDC5/Ir is suspected of inhibiting the epithelial-mesenchymal transition (EMT) process. This relationship has been poorly studied for brea...
Autores principales: | Cebulski, Kamil, Piotrowska, Aleksandra, Kmiecik, Alicja, Haczkiewicz-Leśniak, Katarzyna, Ciesielska, Urszula, Grzegrzółka, Jędrzej, Jabłońska, Karolina, Romanowicz, Hanna, Smolarz, Beata, Dzięgiel, Piotr, Podhorska-Okołów, Marzenna, Nowińska, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218226/ https://www.ncbi.nlm.nih.gov/pubmed/37239973 http://dx.doi.org/10.3390/ijms24108628 |
Ejemplares similares
-
Expression of Irisin/FNDC5 in Breast Cancer
por: Cebulski, Kamil, et al.
Publicado: (2022) -
Association of Irisin/FNDC5 with ERRα and PGC-1α Expression in NSCLC
por: Nowińska, Katarzyna, et al.
Publicado: (2022) -
Expression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-Small Cell Lung Cancer
por: Nowinska, Katarzyna, et al.
Publicado: (2019) -
Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers
por: Pawelczyk, Konrad, et al.
Publicado: (2019) -
The Role of Irisin in Cancer Disease
por: Pinkowska, Agnieszka, et al.
Publicado: (2021)